NCT02858986

Brief Summary

Introduction: Three-dimensional key-hole surgery ('laparoscopic') systems are proven to reduce the time required to complete tasks in laboratory settings. This benefit derives from the addition of binocular depth perception cues when compared to two-dimensional (2D) systems. This year a '4K' laparoscopic system has become commercially available, so-named as it provides a high resolution 2D image with four times the number of pixels of 2D full high definition. The improved visualisation is likely to provide additional non-binocular depth cues. It is currently unclear to what degree improving the resolution of 2D systems can compensate for binocular depth cues. Aim: To determine whether the binocular vision provided by 3D laparoscopic systems provides benefits during laparoscopic cholecystectomy when compared to the monocular vision provided by high-resolution 4K systems. Methods: A randomised controlled trial of 3D HD versus 4K laparoscopic systems will be performed, comparing the time to complete laparoscopic cholecystectomy, and error scores. Impact: This study is a unique, first-of-its-kind investigation into two new surgical technologies, and is the first study to involve a 4K system. The uptake of three-dimensional systems has been curbed by financial cost and the limitations of early 3D technologies. This study aims to determine which system may be the safest, quickest and most cost- effective, in order to guide future investment and technological development towards either 3D or 2D systems. In addition, these systems may also aid in the learning curve of trainee surgeons.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

September 19, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2017

Completed
Last Updated

February 19, 2019

Status Verified

February 1, 2019

Enrollment Period

11 months

First QC Date

August 1, 2016

Last Update Submit

February 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time for completion of the key steps in laparoscopic cholecystectomy

    Day of surgery

Secondary Outcomes (1)

  • Errors detected on video analysis of laparoscopic cholecystectomy as defined by a validated checklist

    Day of surgery

Study Arms (2)

3D laparoscopy

EXPERIMENTAL

Patients will undergo laparoscopic cholecystectomy using a 3D laparoscopic system

Procedure: 3D laparoscopy

4K laparoscopy

EXPERIMENTAL

Patients will undergo laparoscopic cholecystectomy using a 4K laparoscopic system

Procedure: 4K laparoscopy

Interventions

3D laparoscopy
4K laparoscopy

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed, written consent obtained after provision of information leaflets and face-to-face answering of any questions participants may have
  • Elective laparoscopic cholecystectomy
  • Medically fit for discharge as day case
  • Age 18 to 85 years

You may not qualify if:

  • Unable to obtain informed, written consent
  • Emergency cholecystectomy
  • Not medically fit for discharge as day case
  • Age \<18 or \>85 years
  • Conversion to open cholecystectomy
  • History of upper abdominal surgery
  • Recent/current involvement in another clinical trial
  • Common bile duct exploration at time of operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CholecystitisGallstones

Condition Hierarchy (Ancestors)

Gallbladder DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasisCholecystolithiasisCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Surgical Research Registrar

Study Record Dates

First Submitted

August 1, 2016

First Posted

August 8, 2016

Study Start

September 19, 2016

Primary Completion

August 29, 2017

Study Completion

October 3, 2017

Last Updated

February 19, 2019

Record last verified: 2019-02